Information Journal Paper
APA:
Copy. (2020). The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents. CRITICAL CARE, 24(1), 0-0. SID. https://sid.ir/paper/991471/en
Vancouver:
Copy. The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents. CRITICAL CARE[Internet]. 2020;24(1):0-0. Available from: https://sid.ir/paper/991471/en
IEEE:
Copy, “The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents,” CRITICAL CARE, vol. 24, no. 1, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/991471/en